COVID-19 Impact on Global Clinical Next-Generation Sequencing Market Size, Status and Forecast 2020-2026
Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Clinical Next-Generation Sequencing market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Clinical Next-Generation Sequencing industry.
Based on our recent survey, we have several different scenarios about the Clinical Next-Generation Sequencing YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Clinical Next-Generation Sequencing will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Next-Generation Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Next-Generation Sequencing market in terms of revenue.
Players, stakeholders, and other participants in the global Clinical Next-Generation Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Clinical Next-Generation Sequencing market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Clinical Next-Generation Sequencing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Next-Generation Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Next-Generation Sequencing market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Clinical Next-Generation Sequencing market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Clinical Next-Generation Sequencing industry.
Based on our recent survey, we have several different scenarios about the Clinical Next-Generation Sequencing YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Clinical Next-Generation Sequencing will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Next-Generation Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Next-Generation Sequencing market in terms of revenue.
Players, stakeholders, and other participants in the global Clinical Next-Generation Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Clinical Next-Generation Sequencing market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Clinical Next-Generation Sequencing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Next-Generation Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Next-Generation Sequencing market.
The following players are covered in this report:
- Thermo Fisher Scientific
- PerkinElmer
- Illumina
- Beckman Coulter
- GATC Biotech
- Qiagen
- Targeted Sequencing
- Exome Sequencing
- Others
- Hospitals and Clinics
- Biopharma Companies
- Academic and Research Organizations
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Clinical Next-Generation Sequencing Revenue
1.4 Market Analysis by Type
1.4.1 Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Targeted Sequencing
1.4.3 Exome Sequencing
1.4.4 Others
1.5 Market by Application
1.5.1 Global Clinical Next-Generation Sequencing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Biopharma Companies
1.5.4 Academic and Research Organizations
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Clinical Next-Generation Sequencing Industry Impact
1.6.1 How the Covid-19 is Affecting the Clinical Next-Generation Sequencing Industry
1.6.1.1 Clinical Next-Generation Sequencing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Clinical Next-Generation Sequencing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Clinical Next-Generation Sequencing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Clinical Next-Generation Sequencing Market Perspective (2015-2026)
2.2 Clinical Next-Generation Sequencing Growth Trends by Regions
2.2.1 Clinical Next-Generation Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Clinical Next-Generation Sequencing Historic Market Share by Regions (2015-2020)
2.2.3 Clinical Next-Generation Sequencing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Clinical Next-Generation Sequencing Market Growth Strategy
2.3.6 Primary Interviews with Key Clinical Next-Generation Sequencing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Clinical Next-Generation Sequencing Players by Market Size
3.1.1 Global Top Clinical Next-Generation Sequencing Players by Revenue (2015-2020)
3.1.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Players (2015-2020)
3.1.3 Global Clinical Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Clinical Next-Generation Sequencing Market Concentration Ratio
3.2.1 Global Clinical Next-Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Clinical Next-Generation Sequencing Revenue in 2019
3.3 Clinical Next-Generation Sequencing Key Players Head office and Area Served
3.4 Key Players Clinical Next-Generation Sequencing Product Solution and Service
3.5 Date of Enter into Clinical Next-Generation Sequencing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Clinical Next-Generation Sequencing Historic Market Size by Type (2015-2020)
4.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2021-2026)
5 CLINICAL NEXT-GENERATION SEQUENCING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
5.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Clinical Next-Generation Sequencing Market Size (2015-2020)
6.2 Clinical Next-Generation Sequencing Key Players in North America (2019-2020)
6.3 North America Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
6.4 North America Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Clinical Next-Generation Sequencing Market Size (2015-2020)
7.2 Clinical Next-Generation Sequencing Key Players in Europe (2019-2020)
7.3 Europe Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
7.4 Europe Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
8 CHINA
8.1 China Clinical Next-Generation Sequencing Market Size (2015-2020)
8.2 Clinical Next-Generation Sequencing Key Players in China (2019-2020)
8.3 China Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
8.4 China Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Clinical Next-Generation Sequencing Market Size (2015-2020)
9.2 Clinical Next-Generation Sequencing Key Players in Japan (2019-2020)
9.3 Japan Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
9.4 Japan Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Clinical Next-Generation Sequencing Market Size (2015-2020)
10.2 Clinical Next-Generation Sequencing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
10.4 Southeast Asia Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
11 INDIA
11.1 India Clinical Next-Generation Sequencing Market Size (2015-2020)
11.2 Clinical Next-Generation Sequencing Key Players in India (2019-2020)
11.3 India Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
11.4 India Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Clinical Next-Generation Sequencing Market Size (2015-2020)
12.2 Clinical Next-Generation Sequencing Key Players in Central & South America (2019-2020)
12.3 Central & South America Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
12.4 Central & South America Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Introduction
13.1.4 Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 PerkinElmer
13.2.1 PerkinElmer Company Details
13.2.2 PerkinElmer Business Overview and Its Total Revenue
13.2.3 PerkinElmer Clinical Next-Generation Sequencing Introduction
13.2.4 PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.2.5 PerkinElmer Recent Development
13.3 Illumina
13.3.1 Illumina Company Details
13.3.2 Illumina Business Overview and Its Total Revenue
13.3.3 Illumina Clinical Next-Generation Sequencing Introduction
13.3.4 Illumina Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.3.5 Illumina Recent Development
13.4 Beckman Coulter
13.4.1 Beckman Coulter Company Details
13.4.2 Beckman Coulter Business Overview and Its Total Revenue
13.4.3 Beckman Coulter Clinical Next-Generation Sequencing Introduction
13.4.4 Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.4.5 Beckman Coulter Recent Development
13.5 GATC Biotech
13.5.1 GATC Biotech Company Details
13.5.2 GATC Biotech Business Overview and Its Total Revenue
13.5.3 GATC Biotech Clinical Next-Generation Sequencing Introduction
13.5.4 GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.5.5 GATC Biotech Recent Development
13.6 Qiagen
13.6.1 Qiagen Company Details
13.6.2 Qiagen Business Overview and Its Total Revenue
13.6.3 Qiagen Clinical Next-Generation Sequencing Introduction
13.6.4 Qiagen Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.6.5 Qiagen Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Clinical Next-Generation Sequencing Revenue
1.4 Market Analysis by Type
1.4.1 Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Targeted Sequencing
1.4.3 Exome Sequencing
1.4.4 Others
1.5 Market by Application
1.5.1 Global Clinical Next-Generation Sequencing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Biopharma Companies
1.5.4 Academic and Research Organizations
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Clinical Next-Generation Sequencing Industry Impact
1.6.1 How the Covid-19 is Affecting the Clinical Next-Generation Sequencing Industry
1.6.1.1 Clinical Next-Generation Sequencing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Clinical Next-Generation Sequencing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Clinical Next-Generation Sequencing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Clinical Next-Generation Sequencing Market Perspective (2015-2026)
2.2 Clinical Next-Generation Sequencing Growth Trends by Regions
2.2.1 Clinical Next-Generation Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Clinical Next-Generation Sequencing Historic Market Share by Regions (2015-2020)
2.2.3 Clinical Next-Generation Sequencing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Clinical Next-Generation Sequencing Market Growth Strategy
2.3.6 Primary Interviews with Key Clinical Next-Generation Sequencing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Clinical Next-Generation Sequencing Players by Market Size
3.1.1 Global Top Clinical Next-Generation Sequencing Players by Revenue (2015-2020)
3.1.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Players (2015-2020)
3.1.3 Global Clinical Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Clinical Next-Generation Sequencing Market Concentration Ratio
3.2.1 Global Clinical Next-Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Clinical Next-Generation Sequencing Revenue in 2019
3.3 Clinical Next-Generation Sequencing Key Players Head office and Area Served
3.4 Key Players Clinical Next-Generation Sequencing Product Solution and Service
3.5 Date of Enter into Clinical Next-Generation Sequencing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Clinical Next-Generation Sequencing Historic Market Size by Type (2015-2020)
4.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2021-2026)
5 CLINICAL NEXT-GENERATION SEQUENCING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
5.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Clinical Next-Generation Sequencing Market Size (2015-2020)
6.2 Clinical Next-Generation Sequencing Key Players in North America (2019-2020)
6.3 North America Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
6.4 North America Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Clinical Next-Generation Sequencing Market Size (2015-2020)
7.2 Clinical Next-Generation Sequencing Key Players in Europe (2019-2020)
7.3 Europe Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
7.4 Europe Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
8 CHINA
8.1 China Clinical Next-Generation Sequencing Market Size (2015-2020)
8.2 Clinical Next-Generation Sequencing Key Players in China (2019-2020)
8.3 China Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
8.4 China Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Clinical Next-Generation Sequencing Market Size (2015-2020)
9.2 Clinical Next-Generation Sequencing Key Players in Japan (2019-2020)
9.3 Japan Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
9.4 Japan Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Clinical Next-Generation Sequencing Market Size (2015-2020)
10.2 Clinical Next-Generation Sequencing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
10.4 Southeast Asia Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
11 INDIA
11.1 India Clinical Next-Generation Sequencing Market Size (2015-2020)
11.2 Clinical Next-Generation Sequencing Key Players in India (2019-2020)
11.3 India Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
11.4 India Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Clinical Next-Generation Sequencing Market Size (2015-2020)
12.2 Clinical Next-Generation Sequencing Key Players in Central & South America (2019-2020)
12.3 Central & South America Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
12.4 Central & South America Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Introduction
13.1.4 Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 PerkinElmer
13.2.1 PerkinElmer Company Details
13.2.2 PerkinElmer Business Overview and Its Total Revenue
13.2.3 PerkinElmer Clinical Next-Generation Sequencing Introduction
13.2.4 PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.2.5 PerkinElmer Recent Development
13.3 Illumina
13.3.1 Illumina Company Details
13.3.2 Illumina Business Overview and Its Total Revenue
13.3.3 Illumina Clinical Next-Generation Sequencing Introduction
13.3.4 Illumina Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.3.5 Illumina Recent Development
13.4 Beckman Coulter
13.4.1 Beckman Coulter Company Details
13.4.2 Beckman Coulter Business Overview and Its Total Revenue
13.4.3 Beckman Coulter Clinical Next-Generation Sequencing Introduction
13.4.4 Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.4.5 Beckman Coulter Recent Development
13.5 GATC Biotech
13.5.1 GATC Biotech Company Details
13.5.2 GATC Biotech Business Overview and Its Total Revenue
13.5.3 GATC Biotech Clinical Next-Generation Sequencing Introduction
13.5.4 GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.5.5 GATC Biotech Recent Development
13.6 Qiagen
13.6.1 Qiagen Company Details
13.6.2 Qiagen Business Overview and Its Total Revenue
13.6.3 Qiagen Clinical Next-Generation Sequencing Introduction
13.6.4 Qiagen Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
13.6.5 Qiagen Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Clinical Next-Generation Sequencing Key Market Segments
Table 2. Key Players Covered: Ranking by Clinical Next-Generation Sequencing Revenue
Table 3. Ranking of Global Top Clinical Next-Generation Sequencing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Targeted Sequencing
Table 6. Key Players of Exome Sequencing
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Clinical Next-Generation Sequencing Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Clinical Next-Generation Sequencing Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Clinical Next-Generation Sequencing Players to Combat Covid-19 Impact
Table 13. Global Clinical Next-Generation Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Clinical Next-Generation Sequencing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Clinical Next-Generation Sequencing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Clinical Next-Generation Sequencing Market Share by Regions (2015-2020)
Table 17. Global Clinical Next-Generation Sequencing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Clinical Next-Generation Sequencing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Clinical Next-Generation Sequencing Market Growth Strategy
Table 23. Main Points Interviewed from Key Clinical Next-Generation Sequencing Players
Table 24. Global Clinical Next-Generation Sequencing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Clinical Next-Generation Sequencing Market Share by Players (2015-2020)
Table 26. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Next-Generation Sequencing as of 2019)
Table 27. Global Clinical Next-Generation Sequencing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Clinical Next-Generation Sequencing Product Solution and Service
Table 30. Date of Enter into Clinical Next-Generation Sequencing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Clinical Next-Generation Sequencing Market Size Share by Type (2015-2020)
Table 34. Global Clinical Next-Generation Sequencing Revenue Market Share by Type (2021-2026)
Table 35. Global Clinical Next-Generation Sequencing Market Size Share by Application (2015-2020)
Table 36. Global Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Clinical Next-Generation Sequencing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 40. North America Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 42. North America Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 44. Europe Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 46. Europe Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 48. Europe Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 50. China Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 52. China Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 53. China Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 54. China Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 55. China Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 56. Japan Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 58. Japan Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 60. Japan Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 64. Southeast Asia Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 66. Southeast Asia Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 68. India Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 70. India Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 71. India Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 72. India Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 73. India Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 76. Central & South America Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 78. Central & South America Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Product
Table 83. Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 84. Thermo Fisher Scientific Recent Development
Table 85. PerkinElmer Company Details
Table 86. PerkinElmer Business Overview
Table 87. PerkinElmer Product
Table 88. PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 89. PerkinElmer Recent Development
Table 90. Illumina Company Details
Table 91. Illumina Business Overview
Table 92. Illumina Product
Table 93. Illumina Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 94. Illumina Recent Development
Table 95. Beckman Coulter Company Details
Table 96. Beckman Coulter Business Overview
Table 97. Beckman Coulter Product
Table 98. Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 99. Beckman Coulter Recent Development
Table 100. GATC Biotech Company Details
Table 101. GATC Biotech Business Overview
Table 102. GATC Biotech Product
Table 103. GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 104. GATC Biotech Recent Development
Table 105. Qiagen Company Details
Table 106. Qiagen Business Overview
Table 107. Qiagen Product
Table 108. Qiagen Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 109. Qiagen Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 1. Clinical Next-Generation Sequencing Key Market Segments
Table 2. Key Players Covered: Ranking by Clinical Next-Generation Sequencing Revenue
Table 3. Ranking of Global Top Clinical Next-Generation Sequencing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Targeted Sequencing
Table 6. Key Players of Exome Sequencing
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Clinical Next-Generation Sequencing Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Clinical Next-Generation Sequencing Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Clinical Next-Generation Sequencing Players to Combat Covid-19 Impact
Table 13. Global Clinical Next-Generation Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Clinical Next-Generation Sequencing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Clinical Next-Generation Sequencing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Clinical Next-Generation Sequencing Market Share by Regions (2015-2020)
Table 17. Global Clinical Next-Generation Sequencing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Clinical Next-Generation Sequencing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Clinical Next-Generation Sequencing Market Growth Strategy
Table 23. Main Points Interviewed from Key Clinical Next-Generation Sequencing Players
Table 24. Global Clinical Next-Generation Sequencing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Clinical Next-Generation Sequencing Market Share by Players (2015-2020)
Table 26. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Next-Generation Sequencing as of 2019)
Table 27. Global Clinical Next-Generation Sequencing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Clinical Next-Generation Sequencing Product Solution and Service
Table 30. Date of Enter into Clinical Next-Generation Sequencing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Clinical Next-Generation Sequencing Market Size Share by Type (2015-2020)
Table 34. Global Clinical Next-Generation Sequencing Revenue Market Share by Type (2021-2026)
Table 35. Global Clinical Next-Generation Sequencing Market Size Share by Application (2015-2020)
Table 36. Global Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Clinical Next-Generation Sequencing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 40. North America Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 42. North America Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 44. Europe Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 46. Europe Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 48. Europe Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 50. China Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 52. China Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 53. China Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 54. China Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 55. China Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 56. Japan Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 58. Japan Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 60. Japan Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 64. Southeast Asia Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 66. Southeast Asia Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 68. India Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 70. India Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 71. India Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 72. India Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 73. India Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Clinical Next-Generation Sequencing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Clinical Next-Generation Sequencing Market Share (2019-2020)
Table 76. Central & South America Clinical Next-Generation Sequencing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Clinical Next-Generation Sequencing Market Share by Type (2015-2020)
Table 78. Central & South America Clinical Next-Generation Sequencing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Clinical Next-Generation Sequencing Market Share by Application (2015-2020)
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Product
Table 83. Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 84. Thermo Fisher Scientific Recent Development
Table 85. PerkinElmer Company Details
Table 86. PerkinElmer Business Overview
Table 87. PerkinElmer Product
Table 88. PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 89. PerkinElmer Recent Development
Table 90. Illumina Company Details
Table 91. Illumina Business Overview
Table 92. Illumina Product
Table 93. Illumina Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 94. Illumina Recent Development
Table 95. Beckman Coulter Company Details
Table 96. Beckman Coulter Business Overview
Table 97. Beckman Coulter Product
Table 98. Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 99. Beckman Coulter Recent Development
Table 100. GATC Biotech Company Details
Table 101. GATC Biotech Business Overview
Table 102. GATC Biotech Product
Table 103. GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 104. GATC Biotech Recent Development
Table 105. Qiagen Company Details
Table 106. Qiagen Business Overview
Table 107. Qiagen Product
Table 108. Qiagen Revenue in Clinical Next-Generation Sequencing Business (2015-2020) (Million US$)
Table 109. Qiagen Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Clinical Next-Generation Sequencing Market Share by Type: 2020 VS 2026
Figure 2. Targeted Sequencing Features
Figure 3. Exome Sequencing Features
Figure 4. Others Features
Figure 5. Global Clinical Next-Generation Sequencing Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and Clinics Case Studies
Figure 7. Biopharma Companies Case Studies
Figure 8. Academic and Research Organizations Case Studies
Figure 9. Others Case Studies
Figure 10. Clinical Next-Generation Sequencing Report Years Considered
Figure 11. Global Clinical Next-Generation Sequencing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Clinical Next-Generation Sequencing Market Share by Regions: 2020 VS 2026
Figure 13. Global Clinical Next-Generation Sequencing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Clinical Next-Generation Sequencing Market Share by Players in 2019
Figure 16. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Next-Generation Sequencing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Clinical Next-Generation Sequencing Revenue in 2019
Figure 18. North America Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Thermo Fisher Scientific Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 27. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. PerkinElmer Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 29. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Illumina Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 31. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Beckman Coulter Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 33. GATC Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GATC Biotech Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 35. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Qiagen Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed
Figure 1. Global Clinical Next-Generation Sequencing Market Share by Type: 2020 VS 2026
Figure 2. Targeted Sequencing Features
Figure 3. Exome Sequencing Features
Figure 4. Others Features
Figure 5. Global Clinical Next-Generation Sequencing Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and Clinics Case Studies
Figure 7. Biopharma Companies Case Studies
Figure 8. Academic and Research Organizations Case Studies
Figure 9. Others Case Studies
Figure 10. Clinical Next-Generation Sequencing Report Years Considered
Figure 11. Global Clinical Next-Generation Sequencing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Clinical Next-Generation Sequencing Market Share by Regions: 2020 VS 2026
Figure 13. Global Clinical Next-Generation Sequencing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Clinical Next-Generation Sequencing Market Share by Players in 2019
Figure 16. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Next-Generation Sequencing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Clinical Next-Generation Sequencing Revenue in 2019
Figure 18. North America Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Clinical Next-Generation Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Thermo Fisher Scientific Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 27. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. PerkinElmer Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 29. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Illumina Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 31. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Beckman Coulter Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 33. GATC Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GATC Biotech Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 35. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Qiagen Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed
